Development of the MC1R Selective Ligands for the Melanoma Prevention

被引：0
|
作者：
Cai, Minying [1 ]
Zhou, Yang [1 ]
Haghighi, Saghar Mowlazadeh [1 ]
Hruby, Victor [1 ]
机构：
[1] Univ Arizona, Tucson, AZ 85721 USA
来源：
JOURNAL OF PEPTIDE SCIENCE | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
OP59
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] MC1R variants and cutaneous melanoma risk in the Southern Brazil population
    Do Nascimento, C. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (09) : B2 - B2
  • [32] Development of Melanoma-Targeted Polymer Micelles by Conjugation of a Melanocortin 1 Receptor (MC1R) Specific Ligand
    Barkey, Natalie M.
    Tafreshi, Narges K.
    Josan, Jatinder S.
    De Silva, Channa R.
    Sill, Kevin N.
    Hruby, Victor J.
    Gillies, Robert J.
    Morse, David L.
    Vagner, Josef
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (23) : 8078 - 8084
  • [33] Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
    Manganelli, Michele
    Guida, Stefania
    Ferretta, Anna
    Pellacani, Giovanni
    Porcelli, Letizia
    Azzariti, Amalia
    Guida, Gabriella
    GENES, 2021, 12 (07)
  • [34] Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma
    Vernali, Steven
    Waxweiler, Weston T.
    Dillon, Patrick M.
    Kanetsky, Peter A.
    Orlow, Irene
    Luo, Li
    Busam, Klaus J.
    Kricker, Anne
    Armstrong, Bruce K.
    Anton-Culver, Hoda
    Gruber, Stephen B.
    Gallagher, Richard P.
    Zanetti, Roberto
    Rosso, Stefano
    Sacchetto, Lidia
    Dwyer, Terence
    Cust, Anne E.
    Ollila, David W.
    Begg, Colin B.
    Berwick, Marianne
    Thomas, Nancy E.
    JAMA DERMATOLOGY, 2017, 153 (10) : 1026 - 1031
  • [35] Associations of phenotypic characteristics, MC1R variants, and prior amelanotic melanoma with incident amelanotic melanoma
    Vernali, S.
    Kanetsky, P. A.
    Orlow, I.
    Luo, L.
    Berwick, M.
    Thomas, N. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S28 - S28
  • [36] MC1R and melanin-based molecular probes for theranostic of melanoma and beyond
    Hui Shi
    Zhen Cheng
    Acta Pharmacologica Sinica, 2022, 43 : 3034 - 3044
  • [37] MC1R germline variants confer risk for BRAF-mutant melanoma
    Landi, Maria Teresa
    Bauer, Juergen
    Pfeiffer, Ruth M.
    Elder, David E.
    Hulley, Benjamin
    Minghetti, Paola
    Calista, Donato
    Kanetsky, Peter A.
    Pinkel, Daniel
    Bastian, Boris C.
    SCIENCE, 2006, 313 (5786) : 521 - 522
  • [38] Interactive effects of MC1R and OCA2 on melanoma risk phenotypes
    Duffy, DL
    Box, NF
    Chen, W
    Palmer, JS
    Montgomery, GW
    James, MR
    Hayward, NK
    Martin, NG
    Sturm, RA
    HUMAN MOLECULAR GENETICS, 2004, 13 (04) : 447 - 461
  • [39] BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma
    Garcia-Casado, Z.
    Traves, V.
    Banuls, J.
    Niveiro, M.
    Gimeno-Carpio, E.
    Jimenez-Sanchez, A. I.
    Moragon, M.
    Onrubia, J. A.
    Oliver, V.
    Kumar, R.
    Nagore, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (04) : 1128 - 1131
  • [40] MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population
    Landi, MT
    Kanetsky, PA
    Tsang, S
    Gold, B
    Munroe, D
    Rebbeck, T
    Swoyer, J
    Ter-Minassian, M
    Hedayati, M
    Grossman, L
    Goldstein, AM
    Calista, D
    Pfeiffer, RM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (13) : 998 - 1007
12345